Literature DB >> 31535177

[Seronegative myasthenic syndrome?]

C Selge1, T Kümpfel2, J Havla2, F Schöberl2, A Danek2, P Reilich2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31535177     DOI： 10.1007/s00115-019-00810-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  5 in total

Review 1.  Nature and Action of Antibodies in Myasthenia Gravis.

Authors:  Robert L Ruff; Robert P Lisak
Journal:  Neurol Clin       Date:  2018-05       Impact factor: 3.806

2.  Antibodies to clustered acetylcholine receptor: expanding the phenotype.

Authors:  P Devic; P Petiot; T Simonet; T Stojkovic; E Delmont; J Franques; A Magot; C Vial; E Lagrange; A S Nicot; V Risson; B Eymard; L Schaeffer
Journal:  Eur J Neurol       Date:  2013-09-21       Impact factor: 6.089

3.  Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis.

Authors:  Pedro M Rodríguez Cruz; Michal Al-Hajjar; Saif Huda; Leslie Jacobson; Mark Woodhall; Sandeep Jayawant; Camilla Buckley; David Hilton-Jones; David Beeson; Angela Vincent; Maria Isabel Leite; Jacqueline Palace
Journal:  JAMA Neurol       Date:  2015-06       Impact factor: 18.302

4.  Clinical application of clustered-AChR for the detection of SNMG.

Authors:  Guang Zhao; Xiaoqing Wang; Xiaowen Yu; Xiutian Zhang; Yangtai Guan; Jianming Jiang
Journal:  Sci Rep       Date:  2015-06-11       Impact factor: 4.379

5.  IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.

Authors:  Maria Isabel Leite; Saiju Jacob; Stuart Viegas; Judy Cossins; Linda Clover; B Paul Morgan; David Beeson; Nick Willcox; Angela Vincent
Journal:  Brain       Date:  2008-05-31       Impact factor: 13.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.